A detailed history of Hanson & Doremus Investment Management transactions in Baxter International Inc stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 1,493 shares of BAX stock, worth $51,717. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,493
Previous 3,905 61.77%
Holding current value
$51,717
Previous $130,000 56.92%
% of portfolio
0.01%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$32.85 - $40.26 $79,234 - $97,107
-2,412 Reduced 61.77%
1,493 $56,000
Q2 2024

Aug 08, 2024

SELL
$32.87 - $43.55 $31,620 - $41,895
-962 Reduced 19.77%
3,905 $130,000
Q1 2024

Apr 22, 2024

SELL
$37.88 - $43.77 $8,068 - $9,323
-213 Reduced 4.19%
4,867 $208,000
Q4 2023

Jan 25, 2024

SELL
$31.71 - $38.95 $7,705 - $9,464
-243 Reduced 4.57%
5,080 $196,000
Q3 2023

Oct 24, 2023

SELL
$37.32 - $49.29 $35,603 - $47,022
-954 Reduced 15.2%
5,323 $200,000
Q2 2023

Jul 18, 2023

SELL
$39.98 - $47.68 $51,774 - $61,745
-1,295 Reduced 17.1%
6,277 $285,000
Q1 2023

Apr 18, 2023

SELL
$37.58 - $52.57 $36,753 - $51,413
-978 Reduced 11.44%
7,572 $307,000
Q4 2022

Jan 18, 2023

SELL
$49.7 - $57.71 $68,188 - $79,178
-1,372 Reduced 13.83%
8,550 $436,000
Q2 2022

Jul 19, 2022

SELL
$63.83 - $80.0 $37,340 - $46,800
-585 Reduced 5.57%
9,922 $637,000
Q1 2022

Apr 22, 2022

SELL
$76.85 - $89.45 $16,522 - $19,231
-215 Reduced 2.01%
10,507 $815,000
Q4 2021

Jan 20, 2022

SELL
$74.57 - $87.19 $2,684 - $3,138
-36 Reduced 0.33%
10,722 $920,000
Q3 2021

Oct 21, 2021

SELL
$73.77 - $83.61 $68,532 - $77,673
-929 Reduced 7.95%
10,758 $865,000
Q2 2021

Jul 22, 2021

SELL
$80.5 - $88.01 $33,407 - $36,524
-415 Reduced 3.43%
11,687 $940,000
Q1 2021

May 03, 2021

SELL
$76.38 - $86.03 $76 - $86
-1 Reduced 0.01%
12,102 $1.02 Million
Q4 2020

Feb 01, 2021

BUY
$75.39 - $82.36 $31,362 - $34,261
416 Added 3.56%
12,103 $971,000
Q3 2020

Oct 19, 2020

SELL
$78.33 - $90.73 $23,577 - $27,309
-301 Reduced 2.51%
11,687 $940,000
Q2 2020

Jul 17, 2020

SELL
$78.66 - $94.14 $66,074 - $79,077
-840 Reduced 6.55%
11,988 $1.03 Million
Q1 2020

Apr 24, 2020

BUY
$71.57 - $93.3 $21,828 - $28,456
305 Added 2.44%
12,828 $1.04 Million
Q4 2019

Jan 16, 2020

SELL
$76.7 - $88.45 $1,917 - $2,211
-25 Reduced 0.2%
12,523 $1.05 Million
Q3 2019

Oct 18, 2019

SELL
$81.4 - $89.78 $30,769 - $33,936
-378 Reduced 2.92%
12,548 $1.1 Million
Q2 2019

Jul 18, 2019

BUY
$73.44 - $82.41 $1,175 - $1,318
16 Added 0.12%
12,926 $1.06 Million
Q1 2019

Apr 23, 2019

SELL
$64.48 - $81.31 $43,717 - $55,128
-678 Reduced 4.99%
12,910 $0
Q4 2018

Jan 31, 2019

SELL
$61.45 - $77.8 $19,786 - $25,051
-322 Reduced 2.31%
13,588 $894,000
Q3 2018

Oct 24, 2018

SELL
$70.71 - $77.75 $20,435 - $22,469
-289 Reduced 2.04%
13,910 $0
Q2 2018

Aug 08, 2018

SELL
$63.43 - $75.41 $51,061 - $60,705
-805 Reduced 5.37%
14,199 $1.05 Million
Q1 2018

May 10, 2018

BUY
$62.56 - $72.26 $35,972 - $41,549
575 Added 3.99%
15,004 $976,000
Q4 2017

Jan 25, 2018

SELL
$61.45 - $66.05 $4,916 - $5,284
-80 Reduced 0.55%
14,429 $933,000
Q3 2017

Oct 26, 2017

BUY
$59.5 - $64.61 $863,285 - $937,426
14,509
14,509 $0

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Hanson & Doremus Investment Management Portfolio

Follow Hanson & Doremus Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.